Strain differences in profiles of dopaminergic neurotransmission in the prefrontal cortex of the BALB/C vs. C57Bl/6 mice: Consequences of stress and afobazole

European Journal of Pharmacology

Volumn 708, Issue 1-3, 2013, Pages 95-104

  Anderzhanova, Elmira A ^a   Bächli, Heidi ^c   Buneeva, Olga A ^d   Narkevich, Victor B ^b   Medvedev, Alexei E ^d   Thoeringer, Christoph K ^e   Wotjak, Carsten T ^a   Kudrin, Vladimir S ^b  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b INSTITUTE OF PHARMACOLOGY   (Russian Federation)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^d INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^e TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Afobazole; Anxiety; BALB C mice; C57Bl 6 mice; Dopamine; MAO; Microdialysis; Stress

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; AFOBAZOLE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; ANXIOLYTIC AGENT; DOPAMINE; HOMOVANILLIC ACID; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY DISORDER; ARTICLE; BIOACCUMULATION; BRAIN LEVEL; CATABOLISM; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINE RELEASE; DOPAMINERGIC TRANSMISSION; ENZYME INHIBITION; IN VITRO STUDY; MALE; MAZE TEST; MICRODIALYSIS; NEUROMODULATION; NONHUMAN; OPEN FIELD TEST; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE; STRESS; TRANQUILIZING ACTIVITY; TREATMENT OUTCOME;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; BEHAVIOR, ANIMAL; BENZIMIDAZOLES; DOPAMINE; HOMOVANILLIC ACID; HYDROXYINDOLEACETIC ACID; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MITOCHONDRIA; MONOAMINE OXIDASE; MORPHOLINES; PREFRONTAL CORTEX; SPECIES SPECIFICITY; STRESS, PSYCHOLOGICAL; SYNAPTIC TRANSMISSION;

EID: 84877051899     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.03.015     Document Type: Article

References (59)

1. H.C. Akunne, K.T. Zoski, S.Z. Whetzel, J.J. Cordon, R.M. Brandon, F. Roman, and T.A. Pugsley Neuropharmacological profile of a selective sigma ligand, igmesine: a potential antidepressant Neuropharmacology 41 2001 138 149
2. G. Aston-Jones, and J.D. Cohen An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance Ann. Rev. Neurosci. 28 2005 403 450
3. K. Benchenane, A. Peyrache, M. Khamassi, P.L. Tierney, Y. Gioanni, F.P. Battaglia, and S.I. Wiener Coherent theta oscillations and reorganization of spike timing in the hippocampal-prefrontal network upon learning Neuron 24 2010 921 936
4. R. Bergeron, G. Debonnel, and C. De Montigny Modification of the N-methyl-D-aspartate response by antidepressant sigma receptor ligands Eur. J. Pharmacol. 240 1993 319 323
5. M. Bortolato, S.C. Godar, S. Davarian, K. Chen, and J.C. Shih Behavioral disinhibition and reduced anxiety-like behaviors in monoamine oxidase B-deficient mice Neuropsychopharmacology 34 2009 2746 2757
6. V. Boulougouris, and E. Tsaltas Serotonergic and dopaminergic modulation of attentional processes Prog. Brain Res. 172 2008 17 42
7. P.L. Broadhurst The Maudsley reactive and nonreactive strains of rats: a clarification Behav. Genet. 6 1976 363 365
8. V. Carola, F. D'Olimpio, E. Brunamonti, A. Bevilacqua, P. Renzi, and F. Mangia Anxiety-related behaviour in C57BL/6 <-> BALB/c chimeric mice Behav. Brain Res. 150 2004 25 32
9. J.J. Cerqueira, F. Mailliet, O.F.X. Almeida, T.M. Jay, and N. Sousa The prefrontal cortex as a key target of the maladaptive response to stress J. Neurosci. 27 2007 2781 2787
10. K. Chen, and J. Shih Monoamineoxidase A and B: structure, function, and behavior D.S. Goldstein, D. Eisenhofer, R. McCarty, Cathecholamines. Driving Basis Science with Clinical Medicine 1998 Academic Press San Diego 292 296
11. R. Cools, and M. D'Esposito Inverted-U-shaped dopamine actions on human working memory and cognitive control Biol. Psychiatry 69 2011 113 125
12. J. Cuevas, A. Behensky, W. Deng, and C. Katnik Afobazole modulates neuronal response to ischemia and acidosis via activation of {sigma}-1 receptors J. Pharmacol. Exp. Ther. 339 2011 152 160
13. J.N. Crawley, J.K. Belknap, A. Collins, J.C. Crabbe, W. Frankel, N. Henderson, R.J. Hitzemann, S.C. Maxson, L.L. Miner, A.J. Silva, J.M. Wehner, A. Wynshaw-Boris, and R. Paylor Behavioural phenotypes of inbred mouse strains: implications and recommendations for molecular studies Psychopharmacology 132 1997 107 124
14. A.I. Davydova, P.M. Klodt, V.S. Kudrin, E.A. Kuznetsova, and V.B. Narkevich Neurochemical study of effects of the new anxiolytic drugs afobazol and ladasten on the synthesis and metabolism of monoamines and their metabolites in the brain structures of Wistar rat on the model of monoamine synthesis blockade induced by aromatic amino acid decarboxylase inhibitor NSD-1015 Eksp. Klin. Farmakol. 73 2010 2 6
15. D. Durstewitz, and K. Seaman The dual-state theory of prefrontal cortex dopamine function with relevance to catechol-o-methyltransferase genotypes and schizophrenia Biol. Psychiatry 64 2008 739 749
16. S.J. Fallon, C.H. Williams-Gray, R.A. Barker, A.M. Owen, and A. Hampshire Prefrontal dopamine levels determine the balance between cognitive stability and flexibility Cereb. Cortex 2012 PMID: 22351648
17. G.D. Ferguson, H.R. Herschman, and D.R. Storm Reduced anxiety and depression-like behavior in synaptotagmin IV (-/-) mice Neuropharmacology 47 2004 604 611
18. S.E. File Factors controllingmeasures of anxiety and responses to novelty in the mouse Behav. Brain. Res. 125 2001 151 157
19. S.B. Floresco, Y. Zhang, and T. Enomoto Neural circuits subserving behavioral flexibility and their relevance to schizophrenia Behav. Brain. Res. 204 2009 396 409
20. S.C. Fowler, T.J. Zarcone, and E. Vorontsova Haloperiodol-induced microcatalepsy differs in CD-1, BALB/c, and C57BL/6 mice Exp. Clin. Psychopharmacol. 9 2001 277 284
21. P.A. Garris, and R.M. Wightman Different kinetics govern dopaminergic transmission in the amygdala, prefrontal cortex and striatum: and in vivo voltammetric study J. Neurosci. 14 1994 442 450
22. M. Gesi, A. Santinami, R. Ruffoli, G. Conti, and F. Fornai Novel aspects of dopamine oxidative metabolism (confounding outcomes take place of certainties) Pharm. Toxicol. 89 2001 217 224
23. Y. Goto, C.R. Yang, and S. Otani Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders Biol. Psychiatry 67 2010 199 207
24. A.A. Grace The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving Addict. Suppl. 2 2000 S119 128
25. G. Griebel, C. Belzung, G. Perrault, and D.J. Sanger Differences in anxiety-related behaviours and sensitivity to diazepam in inbred and outbred strains of mice Psychopharmacology 148 2000 164 170
26. J. Grimsby, M. Toth, K. Chen, T. Kumazawa, L. Klaidman, J.D. Adams, F. Karoum, J. Gal, and J.C. Shih Increased stress response and beta- phenylethylamine in MAOB-deficient mice Nat. Genet. 17 1997 206 210
27. A. Holmes, and C.L. Wellman Stress-induced prefrontal reorganization and executive dysfunction in rodents Neurosci. Behav. Rev. 333 2009 773 783
28. I. Kastenberger, C. Lutsch, H. Herzog, and C. Schwarzer Influence of sex and genetic background on anxiety-related and stress-induced behaviour of prodynorphin-deficient mice PLoS One 7 3 2012 e34251 PMID: 22479578
29. N.V. Kaverina, E.P. Popova, M.A. Iarkova, and S.B. Seredenin Afobazole effects on heart rate variability in rats with different behaviors in the "open field" test Eksp. Klin. Farmakol. 72 2009 33 40
30. V.S. Kudrin A comparative study of the effect of afobazole on brain monoamine systems in BALB/C and C57Bl/6 mice Eksp. Klin. Farmakol. 69 2006 7 10
31. S.K. Kulkarni, and A. Dhir On the mechanism of antidepressant-like action of berberine chloride Eur. J. Pharmacol. 589 2008 163 172
32. A. Kuzmin, N. Madjid, L. Terenius, S.O. Ogren, and G. Bakalkin Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice Neuropsychopharmacology 31 2006 1928 1937
33. R. Lalonde, and C. Strazielle Relations between open-field, elevated plus-maze, and emergence tests as displayed by C57/BL6J and BALB/c mice J. Neurosci. Methods 171 2008 48 52
34. M. Le Moal, and H. Simon Mesocorticolimbic dopaminergic network: functional and regulatory roles Physiol. Rev. 71 1991 155 234
35. P. Levitt, J.E. Pinta, and X.O. Breakefiels Immunocytochemical demonstration of monoamineoxidase B in brain astrocites and serotoninergic neurons Proc. Natl. Acad. Sci. USA 79 1982 6385 6389
36. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randal Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 1951 265 275
37. A.E. Medvedev, A.Z. Kirkel, N.S. Kamyshanskaya, L.N. Axenova, T.A. Moskvitina, V.Z. Gorkin, N.I. Andreeva, S.M. Golovina, and M.D. Mashkovsky Inhibition of monoamine oxidase by novel antidepressant tetrindole Biochem. Pharmacol. 47 1994 303 308
38. F.P. Monnet Sigma-1 receptor as regulator of neuronal intracellular Ca2+: clinical and therapeutic relevance Biol. Cell 97 2005 873 883
39. A.A. Moustafa, and M.A. Gluck A neurocomputational model of dopamine and prefrontal-striatal interactions during multicue category learning by Parkinson patients Neural Networks 24 2011 575 591
40. G. Paxinos, and K.B.J. Franklin A Stereotaxic Atlas of the Mouse Brain 2001 Academic Press San Diego, CA
41. N.K. Popova, L.N. Maslova, E.A. Morosova, V.V. Bulygina, and I. Seif MAO-A knockout attenuates adrenocortical response to various kinds of stress Psychoneuroendocrinology 31 2006 179 186
42. R.B. Raffa Screen of receptor and uptake-site activity of hypericin component of St. John's work reveals sigma receptor binding Life Sci. 62 1998 PL265 270
43. M.E. Rice, and S.J. Cragg Dopamine spillover after quantal release: rethinking opamine transmission in the nigrostriatal pathway Brain Res. Rev. 58 2008 303 313
44. R.H. Roth, L.C. Murrin, and J. Waiters Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid Eur. J. Pharmacol. 36 1976 163 171
45. J.K. Seamans, and C.R. Yang The principal features and mechanisms of dopamine modulation in the prefrontal cortex Prog. Neurobiol. 74 2004 1 58
46. S.B. Seredenin, and Yu.A. Blednov Individual variability in the effects of single-dose tranquilizers in neurotic patients: clinical, electroencephalographic and prognostic aspects SB Seredenin, V Longo, G Gaviraghi, Biological Basis of Individual Sensitivity to Psychotropic Drugs 1994 Grasham Press Edinburgh 293 298
47. S.B. Seredenin, G.M. Molodavkin, M.V. Voronin, and T.A. Voronina Antidepressant properties of afobazole in Porsolt and Nomura tests Eksp. Klin. Farmakol. 72 2009 19 21
48. S.B. Seredenin, and M.V. Voronin Neuroreceptor mechanisms of the afobazole effect Eksp. Klin. Farmakol. 72 2009 3 11
49. S.B. Seredin, D.S. Melkumian, E.A. Val'dman, M.A. Iarkova, T.C. Seredina, M.V. Voronin, and A.S. Lapitskaia Effects of afobazole on the BDNF content in brain structures of inbred mice with different phenotypes of emotional stress reaction Eksp. Klin. Farmakol. 69 2006 3 6
50. J.C. Shih, K. Chen, and M.J. Ridd Role of MAO A and B in neurotransmitter metabolism and behavior Pol. J. Pharmacol. 51 1999 25 29
51. W.B. Siesser, X. Zhang, J.P. Jacobsen, T.D. Sotnikova, R.R. Gainetdinov, and M.G. Caron Tryptophan hydroxylase 2 genotype determines brain serotonin synthesis but not tissue content in C57Bl/6 and BALB/c congenic mice Neurosci. Lett. 481 2010 6 11
52. D.J. Stein, H.G. Westenberg, and M.R. Liebowitz Social anxiety disorder and generalized anxiety disorder: serotonergic and dopaminergic neurocircuitry J. Clin. Psychiatry 63 Suppl 6 2002 12 19
53. K. Tottori, T. Miwa, Y. Uwahodo, S. Yamada, M. Nakai, Y. Oshiro, T. Kikuchi, and C.A. Altar Antidepressant-like responses to the combined sigma and 5-HT1A receptor agonist OPC-14523 Neuropharmacology 41 2001 976 988
54. A.A. Uyanaev, V.P. Fisenko, and N.K. Khitrov Effect of nopept and afobazole on the development of neurosis of learned helplessness in rats Bull. Exp. Biol. Med. 136 2003 162 164
55. A.V. Volkova, T.C. Kalinina, and T.A. Voronina Comparative study of the interoceptive effects of afobazole and diazepam Eksp. Klin. Farmakol. 73 2010 2 6
56. M.V. Voronin, L.N. Aksenova, O.A. Buneena, and A.E. Medvedev Effect of afobazole on mitochondrial monoamine oxidase A activity in vitro Bull. Exp. Biol. Med. 148 2009 23 25
57. G.V. Williams, and P.S. Goldman-Rakic Modulation of memory fields by dopamine Dl receptors in prefrontal cortex Nature 376 1995 572 575
58. C.A. Winstanley, D.E. Theobald, J.W. Dalley, R.N. Cardinal, and T.W. Robbins Double dissociation between serotonergic and dopaminergic modulation of medial prefrontal and orbitofrontal cortex during a test of impulsive choice Cereb. Cortex 16 2006 106 114
59. M. Zhou, and N. Panchuk-Voloshina A one-step fluorometric method for the continuous measurement of monoamine oxidase activity Anal. Biochem. 253 1997 169 174